{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:15:51Z","timestamp":1787980551137,"version":"build-2784847793"},"reference-count":35,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,6,15]]},"abstract":"<jats:p>Background: It is suggested that not all individuals with elevated A\u03b2 will develop dementia or cognitive impairment. Environment or lifestyle might modulate the association of amyloid pathology with cognition. Insomnia is a risk factor of cognitive disorders including Alzheimer\u2019s disease. Objective: To investigate if insomnia moderated the relationship between amyloid-\u03b2 (A\u03b2) and longitudinal cognitive performance in non-demented elders. Methods: A total of 385 Alzheimer\u2019s Disease Neuroimaging Initiative participants (mean age\u200a=\u200a73 years, 48% females) who completed 4\u200a+\u200aneuropsychological evaluations and a [18F] florbetapir positron emission tomography scan were followed up to 8 years. Linear mixed-effects regression models were used to examine the interactions effect between insomnia and A\u03b2 on longitudinal cognitive sores, including four domains (memory [MEM], executive function [EF], language [LAN], and visuospatial function [VS]). Results: The A\u03b2-positive status (A+) but not insomnia independently predicted faster cognitive decline in all domains. Furthermore, the relationship between A\u03b2 and cognitive decline was moderated by insomnia (MEM: \u03c72\u200a=\u200a4.05, p\u200a=\u200a0.044, EF: \u03c72\u200a=\u200a4.38, p\u200a=\u200a0.036, LAN: \u03c72\u200a=\u200a4.56, p\u200a=\u200a0.033, and VS: \u03c72\u200a=\u200a4.12, p\u200a=\u200a0.042). Individuals with both elevated A\u03b2 and insomnia experienced faster cognitive decline than those with only elevated A\u03b2 or insomnia. Conclusion: These data reinforced the values of insomnia management in preventing dementia, possibly by interacting A\u03b2 metabolism. Future efforts are warranted to determine whether sleep improvement will postpone the onset of dementia, specifically among populations in stages of preclinical or prodromal AD.<\/jats:p>","DOI":"10.3233\/jad-201582","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T12:53:51Z","timestamp":1620392031000},"page":"1701-1710","source":"Crossref","is-referenced-by-count":16,"title":["Insomnia Moderates the Relationship Between Amyloid-\u03b2 and Cognitive Decline in Late-Life Adults without Dementia"],"prefix":"10.1177","volume":"81","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chen","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Juan","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Qilu Hospital of Shandong University; NHC Key Laboratory of Otorhinolaryngology, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Peng","family":"Cao","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Qingdao Municipal Hospital, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-201582_ref1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2013.193","article-title":"Insomnia","volume":"309","author":"Buysse","year":"2013","journal-title":"JAMA"},{"key":"10.3233\/JAD-201582_ref2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","article-title":"Evidence-based prevention of Alzheimer\u2019s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","volume":"91","author":"Yu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-201582_ref3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/jnnp-2019-321896","article-title":"Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis","volume":"91","author":"Xu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-201582_ref4","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/alz.12117","article-title":"Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in cognitively intact older adults: The CABLE study","volume":"16","author":"Xu","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jamaneurol.2015.3098","article-title":"Association of elevated amyloid levels with cognition and biomarkers in cognitively normal people from the community","volume":"73","author":"Petersen","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-201582_ref6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jalz.2015.12.009","article-title":"Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer\u2019s Prevention study","volume":"12","author":"Clark","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/brain\/awt286","article-title":"Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer\u2019s disease.","volume":"137","author":"Lim","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-201582_ref8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201582_ref9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12035-014-8720-y","article-title":"Cognitive reserve and Alzheimer\u2019s disease","volume":"51","author":"Xu","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-201582_ref10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer\u2019s disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-201582_ref11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jalz.2018.09.008","article-title":"Hypertension and obesity moderate the relationship between beta-amyloid and cognitive decline in midlife.","volume":"15","author":"Clark","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-201582_ref13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","article-title":"Update on the biomarker core of the Alzheimer\u2019s Disease Neuroimaging Initiative subjects","volume":"6","author":"Trojanowski","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jalz.2010.03.007","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative: progress report and future plans.202-211 e","volume":"6","author":"Weiner","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jalz.2012.04.007","article-title":"Worldwide Alzheimer\u2019s disease neuroimaging initiative","volume":"8","author":"Carrillo","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jalz.2015.05.001","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative 2 PET Core: 2015","volume":"11","author":"Jagust","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","article-title":"Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-201582_ref19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2967\/jnumed.111.090340","article-title":"Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer\u2019s disease and cognitively normal subjects","volume":"53","author":"Joshi","year":"2012","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-201582_ref20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201582_ref21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref22","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201582_ref23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","article-title":"Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort","volume":"76","author":"Kim","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-201582_ref24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","article-title":"A composite score for executive functioning, validated in Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.","volume":"6","author":"Gibbons","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.3233\/JAD-201582_ref25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.3233\/JAD-201582_ref26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.clinpsy.032408.153550","article-title":"Advances in analysis of longitudinal data","volume":"6","author":"Gibbons","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"key":"10.3233\/JAD-201582_ref27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25395","article-title":"The impact of amyloid-beta and tau on prospective cognitive decline in older individuals","volume":"85","author":"Sperling","year":"2019","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201582_ref28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.biopsych.2010.10.023","article-title":"Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria\/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey","volume":"69","author":"Roth","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-201582_ref29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40263-018-0535-3","article-title":"A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias","volume":"32","author":"Penninkilampi","year":"2018","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-201582_ref30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"key":"10.3233\/JAD-201582_ref31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.biopsych.2017.11.031","article-title":"The emerging relationship between interstitial fluid-cerebrospinal fluid exchange, amyloid-beta, and sleep","volume":"83","author":"Boespflug","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-201582_ref32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"10.3233\/JAD-201582_ref33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","article-title":"Sleep and Alzheimer disease pathology\u2013a bidirectional relationship","volume":"10","author":"Ju","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-201582_ref34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-019-0478-5","article-title":"Bidirectional relationship between sleep and Alzheimer\u2019s disease: role of amyloid, tau, and other factors","volume":"45","author":"Wang","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-201582_ref35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1474-4422(18)30450-2","article-title":"Implications of sleep disturbance and inflammation for Alzheimer\u2019s disease dementia","volume":"18","author":"Irwin","year":"2019","journal-title":"Lancet Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-201582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:54Z","timestamp":1777370754000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-201582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":35,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-201582","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}